The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say made insulin prices soar.

And lest the wanna-be bullies of public relations (like those called out in a 2021 Mother Jones’ barnburner Amazon exposé) ...

When you’re hunting for work, a text alerting you to a new listing that sounds like your dream job could be your big break.

A seasoned small business and technology writer and educator with more than 20 years of experience, Shweta excels in demystifying complex tech tools and concepts for small businesses. Her work has ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...

In a report from the Federal Trade Commission, the agency accuses large video streaming companies and social media websites ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

U.S. Federal Trade Commission Chair Lina Khan on Friday welcomed that companies are weighing antitrust considerations early ...